Form 8-K - Current report:
SEC Accession No. 0001193125-25-024814
Filing Date
2025-02-12
Accepted
2025-02-12 08:16:30
Documents
15
Period of Report
2025-02-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d876505d8k.htm   iXBRL 8-K 25005
2 EX-99.1 d876505dex991.htm EX-99.1 12181
6 GRAPHIC g876505g0212083145177.jpg GRAPHIC 4037
  Complete submission text file 0001193125-25-024814.txt   173846

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA anro-20250212.xsd EX-101.SCH 2878
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE anro-20250212_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anro-20250212_pre.xml EX-101.PRE 11726
17 EXTRACTED XBRL INSTANCE DOCUMENT d876505d8k_htm.xml XML 3770
Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41944 | Film No.: 25612106
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)